Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109128) titled 'SPF Boreum UVBeat Hydrating & Barrier Protecting Sunscreen SPF 50 PA++++ (SF109)' on April 22.
Study Type: PMS
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Boreum Private Limited
Intervention:
Intervention1: Test Product: UVBeat Hydrating
& Barrier Protecting
Sunscreen SPF 50
PA++++ (SF109): Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour
Control Intervention1: Reference Sunscreen: Quantity 2 mg/sq.cm Route of administr...